General Information of the Compound
Compound ID
CP0258235
Compound Name
3-(4-methylphenyl)-2-propan-2-yl-5,6,7,8-tetrahydro-4H-pyrazolo[3,4-d]azepine
    Show/Hide
Structure
Formula
C17H23N3
Molecular Weight
269.392
Canonical SMILES
CC(C)n1nc2CCNCCc2c1-c1ccc(C)cc1
    Show/Hide
InChI
InChI=1S/C17H23N3/c1-12(2)20-17(14-6-4-13(3)5-7-14)15-8-10-18-11-9-16(15)19-20/h4-7,12,18H,8-11H2,1-3H3
    Show/Hide
InChIKey
OLFYDDVREGSNQJ-UHFFFAOYSA-N
Physicochemical Property
logP
3.12762
Rotatable Bonds
2
Heavy Atom Count
20
Polar Areas
29.85
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11323169
SID: 16412994
ChEMBL ID
CHEMBL4746737
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01746, 5-hydroxytryptamine receptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 6 nM
   TI
   LI
   LO
   TS